Kimia Biosciences Limited (BOM:530313)
India
· Delayed Price · Currency is INR 30.15
-0.11 (-0.36%)
At close: Mar 9, 2026
Kimia Biosciences Revenue
Kimia Biosciences had revenue of 301.01M INR in the quarter ending December 31, 2025, with 0.00% growth. This brings the company's revenue in the last twelve months to 1.26B, up 13.47% year-over-year. In the fiscal year ending March 31, 2025, Kimia Biosciences had annual revenue of 1.19B with 13.39% growth.
Revenue (ttm)
1.26B
Revenue Growth
+13.47%
P/S Ratio
1.13
Revenue / Employee
5.04M
Employees
250
Market Cap
1.43B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.19B | 140.44M | 13.39% |
| Mar 31, 2024 | 1.05B | -236.40M | -18.39% |
| Mar 31, 2023 | 1.29B | 36.15M | 2.89% |
| Mar 31, 2022 | 1.25B | -78.13M | -5.89% |
| Mar 31, 2021 | 1.33B | 264.28M | 24.86% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Smruthi Organics | 1.11B |
| Panchsheel Organics | 1.03B |
| Accretion Nutraveda | 160.49M |
| Krebs Biochemicals & Industries | 230.23M |
| Auro Laboratories | 284.46M |
| Resonance Specialties | 899.72M |
| Tyche Industries | 505.54M |
| Aarey Drugs & Pharmaceuticals | 3.91B |